Press release
Deadline on June 25th coming up in Lawsuit for Investors in Exscientia plc (NASDAQ: EXAI)
A Deadline is coming up on June 25, 2024 in the lawsuit for certain investors in Exscientia plc (NASDAQ: EXAI).
Investors who purchased shares of Exscientia plc (NASDAQ: EXAI) have certain options and there are strict and short deadlines running. Deadline: June 25, 2024. NASDAQ: EXAI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Exscientia plc (NASDAQ: EXAI) common shares between March 23, 2022, and February 12, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 23, 2022, and February 12, 2024, the Defendants made false and/or misleading statements and/or failed to disclose that Defendant Hopkins had engaged in improper relationships with employees that were inconsistent with the Company's standards and values, that Defendant Nicholson had prior knowledge of Defendant Hopkins's relationships and had improperly addressed Hopkins's misconduct without consulting the Board, that the Company's maintenance and enforcement of its Code of Business Conduct and Ethics was inadequate to safeguard against the foregoing conduct, that the foregoing failures subjected the Company to a heightened risk of disruptive leadership transitions and/or reputational harm, and that as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Those who purchased shares of Exscientia plc (NASDAQ: EXAI) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on June 25th coming up in Lawsuit for Investors in Exscientia plc (NASDAQ: EXAI) here
News-ID: 3540041 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of CarMax, Inc. (NYSE: KMX) …
An investor, who purchased shares of CarMax, Inc. (NYSE: KMX), filed a lawsuit over alleged violations of Federal Securities Laws by CarMax, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of CarMax, Inc. (NYSE: KMX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 2, 2026. NYSE: KMX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lantheus Holdings, Inc. (NASDAQ: LNTH) Investor Alert: Deadline in Lawsuit on No …
A deadline is coming up on November 10, 2025 in the lawsuit filed for certain investors of Lantheus Holdings, Inc. (NASDAQ: LNTH) over alleged securities laws violations by Lantheus Holdings, Inc.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and there are strict and short deadlines running. Deadline: November 10, 2025. Lantheus Holdings, Inc. (NASDAQ: LNTH) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Lawsuit filed for Investors who lost money with shares of Synopsys, Inc. (NASDAQ …
An investor, who purchased shares of Synopsys, Inc. (NASDAQ: SNPS), filed a lawsuit over alleged violations of Federal Securities Laws by Synopsys, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Synopsys, Inc. (NASDAQ: SNPS) have certain options and for certain investors are short and strict deadlines running. Deadline: December 30, 2025. NASDAQ: SNPS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investigation announced for Long-Term Investors in shares of Dow Inc. (NYSE: DOW …
An investigation was announced for current long-term investors in shares of Dow Inc. (NYSE: DOW) concerning potential breaches of fiduciary duties by certain directors of Dow Inc.
Investors who are current long term investors in Dow Inc. (NYSE: DOW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: DOW…
More Releases for Exscientia
AI in Biotech Market Is Going to Boom| Major Giants Schrödinger, Healx, Valo H …
HTF MI just released the Global AI in Biotech Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Manufacturers and Players in This Report:
IBM Watson Health, BenevolentAI,…
AI for Drug Discovery and Development Market Is Booming So Rapidly | Major Giant …
According to HTF Market Intelligence, the Global AI for Drug Discovery and Development market to witness a CAGR of 29.6% during the forecast period (2025-2030). The Latest Released AI for Drug Discovery and Development Market Research assesses the future growth potential of the AI for Drug Discovery and Development market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights…
Immuno-Oncology Clinical Trials Market erated Opportunities, Future Scope By 203 …
Overview
The "Immuno-Oncology Clinical Trials Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Immuno-Oncology Clinical Trials industry, as well as predicted future growth, technological advancements, investment prospects,…
AI in Pharmaceutical Market May Set New Growth Story | IBM Watson Health, Benevo …
HTF MI just released the Global AI in Pharmaceutical Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in AI in Pharmaceutical Market are:
IBM Watson Health,…
Investigation announced for Investors in Exscientia plc (NASDAQ: EXAI) over poss …
Exscientia plc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Exscientia plc (NASDAQ: EXAI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Exscientia plc (NASDAQ: EXAI) concerning whether a series of statements by Exscientia…
AI for Drug Discovery Market Seeking Excellent Growth | Exscientia, Cloud Pharma …
Advance Market Analytics published a new research publication on "AI for Drug Discovery Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the AI for Drug Discovery market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive…
